Summary & Overview
CPT 50650: Ureterectomy with Bladder Cuff for Ureteral Cancer
CPT code 50650 denotes the surgical removal of all or part of a ureter with an adjacent bladder cuff, most often performed for ureteral cancer. Nationally, procedures coded with 50650 are significant because they represent definitive surgical management for upper urinary tract malignancies and drive important surgical, perioperative, and oncology-related reimbursement and utilization patterns. This code matters to hospitals, surgical specialists, and payers due to its implications for hospital resource use, postoperative care, and cancer-directed treatment pathways.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, the typical sites of service where 50650 is billed, and the spectrum of common billing modifiers associated with surgical services. The publication provides benchmarks and payer coverage considerations, highlights coding relationships that affect billing and claims adjudication, and summarizes policy and clinical factors that influence utilization of ureterectomy with bladder cuff procedures. The material is geared toward coding professionals, surgical departments, and payer policy teams seeking a national-level reference for CPT code 50650.
Billing Code Overview
CPT code 50650 describes a surgical procedure in which the provider removes all or part of a ureter along with a section of the bladder cuff. This operation is most commonly performed to treat ureteral cancer or other conditions requiring excision of the ureter and an adjacent portion of the bladder.
-
Service type: Surgical excision of ureter with bladder cuff (open or possibly minimally invasive approaches)
-
Typical site of service: Hospital inpatient or hospital outpatient surgery center, depending on clinical stage and complexity
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male presents with painless gross hematuria and flank pain. Imaging with CT urogram demonstrates a 3.2 cm enhancing mass within the distal portion of the right ureter with suspicion for transitional cell carcinoma. After urologic oncology evaluation and cystoscopic biopsy confirming high-grade urothelial carcinoma, the patient is scheduled for a radical nephroureterectomy with removal of the distal ureter and a bladder cuff. Preoperative workflow includes tumor board review, informed consent documenting cancer diagnosis and extent of resection, preoperative labs and anesthesia evaluation, and verification of laterality. The operative team performs open or minimally invasive removal of the kidney and entire ureter with excision of a segment of bladder (bladder cuff) and appropriate lymph node sampling or dissection as indicated. Postoperative care includes inpatient monitoring for bleeding, urine output, pain control, and follow-up pathology to guide adjuvant therapy decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
RT | Right side | Use when procedure is performed on the right ureter/side. |
LT | Left side | Use when procedure is performed on the left ureter/side. |